Aware of the evolutions and challenges in the Nigerian pharmaceutical landscape, CFAO Healthcare and Sanofi, a global pharmaceutical leader, are joining forces, capitalising on their expertise and historical presence to optimise access to quality healthcare.
To this end, CFAO Healthcare will be exclusively distributing the Sanofi General Medicines range in Nigeria through E.P. DIS, the CFAO Healthcare distribution platform. With a continuous presence of 120 years in Nigeria, the CFAO Group is actively deepening its roots, consolidating its position in the country, and making Nigeria the 26th country in the ongoing partnership with Sanofi. The aim is to maintain product availability and quality services for the different local operators and patients.
In 2021, CFAO Healthcare initiated an exclusive partnership with Sanofi for the distribution and marketing of medicines and vaccines across 25 sub-Saharan African countries, both English and French-speaking. This initiative has been highly successful, enhancing trust between the two companies.
In a press statement made available to LEADERSHIP, the CEO & Chairman of CFAO Healthcare, Jean-Marc Leccia, said, “We are delighted to expand our partnership with Sanofi by extending the exclusive distribution of general medicines in Nigeria. CFAO Healthcare is actively strengthening its presence in the Nigerian market to respond effectively to the growing healthcare needs of the population and to secure access to quality medicines.”
The Sanofi General Medicines range, comprising essential pharmaceutical products, underscores CFAO Healthcare and Sanofi’s shared commitment to providing quality therapeutic solutions while solidifying their footprint in the Nigerian market.
Reacting to the partnership, Sanofi Foundation Community Head for Turkey, Africa, & the Middle East at Sanofi, Cem Ozturk, said, “This strategic move represents a significant milestone for our organisation and is driven by our commitment to continually improve access to our medicines and to better serve our patients and the Nigerian health system.”
With an unwavering commitment to the community, CFAO Healthcare is addressing today’s challenges, highlighting the continuity and stability of pharmaceutical distribution. This strategic alliance is dedicated to shaping the future of healthcare in Nigeria.
